Ilevro (nepafenac) NDC 82667-400

NDC codes

FDA NDC Directory

Product NDC (as listed)82667-400Labeler and product segments. Claims need a package NDC.

Product NDC at billing width82667-0400Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
82667-400-03	82667040003	1 BOTTLE, PLASTIC in 1 CARTON (82667-400-03) / 3 mL in 1 BOTTLE, PLASTICMarketed from May 1, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ilevro
Generic name (nonproprietary): nepafenac
Active ingredients: Nepafenac — 3 mg/mL
Dosage form: Suspension/ drops
Route: Ophthalmic
Labeler: Harrow Eye, LLC
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 203491
Marketing start: May 1, 2024
Listing expires: Dec 31, 2027
Other FDA classes: Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)
Identifiers: Product ID 82667-400_4e6f184f-0de5-acca-e063-6394a90ac321SPL ID 4e6f184f-0de5-acca-e063-6394a90ac321SPL set ID 10f411d3-a81e-074a-e063-6294a90ab547RxCUI 1362132, 1365866UNII 0J9L7J6V8C
Pharmacologic class: Nonsteroidal Anti-inflammatory Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N482667040003 followed by a unit qualifier and the quantity

Package 82667-0400-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 1, 2026.

Indications (excerpt from the label)

ILEVRO ® 0.3% is indicated for the treatment of pain and inflammation associated with cataract surgery. ILEVRO ® 0.3% is a nonsteroidal, anti-inflammatory prodrug indicated for the treatment of pain and inflammation associated with cataract surgery ( 1 ).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 203491

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 203491
Product	Strength	Form · route	Labeler	Product NDC
Ilevronepafenac	Nepafenac 3 mg/mL	Suspension/ dropsOphthalmic	Novartis Pharmaceuticals Corporation	0078-0743